How to Respond to FDA Form 483s and Warning Letters
July 10, 2017
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483.
The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Celebrates 50 Years of the Safe Drinking Water Act
December 16, 2024The Safe Drinking Water Act resulted in the creation of NSF/ANSI/CAN 60 and NSF/ANSI/CAN 61, helping safeguard global drinking water.
Read the Story
Brooklands New Media’s Publication On NSF’s Global Animal Wellness Standards (GAWS) Not Endorsed by NSF
November 25, 2024NSF is aware that a firm called Brooklands New Media plans to publish a book to mark the 5th anniversary of NSF Global Animal Wellness Standards (GAWS).
Read the Story
NSF Announces Participation in Sustainable Foods 2025, CNBC Docuseries
November 18, 2024In January 2025, Lisa Spicka de Bevacqua, NSF’s Director of Sustainability Consulting, will speak at the Sustainable Foods 2025 International Conference and Exhibition in London, UK.
Read the Story
NSF CEO Pedro Sancha Joins TIC Council's TIC Talks
November 7, 2024Pedro Sancha reflected on his career journey, leadership approach and insights into the future of public health and the TIC sector.
Read the Story